Literature DB >> 31376890

Thoracic Manifestations of Rheumatoid Arthritis.

Anthony J Esposito1, Sarah G Chu1, Rachna Madan2, Tracy J Doyle1, Paul F Dellaripa3.   

Abstract

Rheumatoid arthritis (RA) is commonly associated with pulmonary disease that can affect any anatomic compartment of the thorax. The most common intrathoracic manifestations of RA include interstitial lung disease, airway disease, pleural disease, rheumatoid nodules, and drug-induced toxicity. Patients with RA with thoracic involvement often present with nonspecific respiratory symptoms, although many are asymptomatic. Therefore, clinicians should routinely consider pulmonary disease when evaluating any patient with RA, particularly one with known risk factors. The optimal screening, diagnostic, and treatment strategies for RA-associated pulmonary disease remain uncertain and are the focus of ongoing investigation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bronchiectasis; Bronchiolitis; Drug-induced lung toxicity; Rheumatoid arthritis; Rheumatoid arthritis–associated interstitial lung disease; Rheumatoid nodule

Mesh:

Year:  2019        PMID: 31376890      PMCID: PMC6994971          DOI: 10.1016/j.ccm.2019.05.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   4.967


  161 in total

1.  Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis.

Authors:  A CAPLAN
Journal:  Thorax       Date:  1953-03       Impact factor: 9.139

2.  Abatacept therapy in rheumatoid arthritis with interstitial lung disease.

Authors:  Antonio Mera-Varela; Eva Pérez-Pampín
Journal:  J Clin Rheumatol       Date:  2014-12       Impact factor: 3.517

3.  Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.

Authors:  J K Dawson; H E Fewins; J Desmond; M P Lynch; D R Graham
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.

Authors:  Karina Raimundo; Joshua J Solomon; Amy L Olson; Amanda M Kong; Ashley L Cole; Aryeh Fischer; Jeffrey J Swigris
Journal:  J Rheumatol       Date:  2018-11-15       Impact factor: 4.666

5.  Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

Authors:  A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

Review 6.  Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis.

Authors:  Riccardo Inchingolo; Francesco Varone; Giacomo Sgalla; Luca Richeldi
Journal:  Expert Rev Respir Med       Date:  2018-12-17       Impact factor: 3.772

7.  Rheumatoid arthritis with pleural effusion includes a subgroup with autoimmune features and HLA-B8, Dw3 association.

Authors:  M Hakala; A Tiilikainen; R Hämeenkorpi; J Ilonen; S Jalava; P Ruuska; R Mäkitalo
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

8.  Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.

Authors:  Eric Toussirot; Jean Marie Berthelot; Edouard Pertuiset; Béatrice Bouvard; Philippe Gaudin; Daniel Wendling; José le Noach; Anne Lohse; Emmanuelle Lecuyer; Le Cri
Journal:  J Rheumatol       Date:  2009-10-01       Impact factor: 4.666

9.  Rituximab-induced interstitial lung disease: five case reports.

Authors:  Matiuallah Naqibullah; Saher B Shaker; Karen S Bach; Elisabeth Bendstrup
Journal:  Eur Clin Respir J       Date:  2015-05-21

10.  Laryngeal manifestations of rheumatoid arthritis.

Authors:  A L Hamdan; D Sarieddine
Journal:  Autoimmune Dis       Date:  2013-06-25
View more
  11 in total

Review 1.  Pleural effusion in psoriatic arthritis patients: a case series and review of the literature.

Authors:  Aliki I Venetsanopoulou; Theodora E Markatseli; Chrisoula Iliou; Zoi Tziortzioti; Maria I Argyropoulou; Alexandros A Drosos; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2021-03-29       Impact factor: 2.980

Review 2.  Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease-A Narrative Review.

Authors:  Alesandra Florescu; Florin Liviu Gherghina; Anca Emanuela Mușetescu; Vlad Pădureanu; Anca Roșu; Mirela Marinela Florescu; Cristina Criveanu; Lucian-Mihai Florescu; Anca Bobircă
Journal:  Biomedicines       Date:  2022-06-09

Review 3.  Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.

Authors:  Elena De Zorzi; Paolo Spagnolo; Elisabetta Cocconcelli; Elisabetta Balestro; Luca Iaccarino; Mariele Gatto; Francesco Benvenuti; Nicol Bernardinello; Andrea Doria; Toby M Maher; Elisabetta Zanatta
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-18       Impact factor: 10.817

4.  Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment.

Authors:  Sicong Huang; Vanessa L Kronzer; Paul F Dellaripa; Kevin D Deane; Marcy B Bolster; Vivek Nagaraja; Dinesh Khanna; Tracy J Doyle; Jeffrey A Sparks
Journal:  Curr Treatm Opt Rheumatol       Date:  2020-09-01

5.  Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis.

Authors:  Ji-Won Kim; Chang-Hee Suh
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

6.  Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent.

Authors:  Eric Senbel; Frederick Durand; Baptiste Roux; Fatima-Zohra Badaoui; Bruno Fautrel
Journal:  Rheumatol Ther       Date:  2021-05-03

7.  Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts.

Authors:  Konstantin Tsoyi; Anthony J Esposito; Bo Sun; Ryan G Bowen; Kevin Xiong; Fernando Poli; Rafael Cardenas; Sarah G Chu; Xiaoliang Liang; Stefan W Ryter; Christine Beeton; Tracy J Doyle; Matthew J Robertson; Lindsay J Celada; Freddy Romero; Souheil Y El-Chemaly; Mark A Perrella; I-Cheng Ho; Ivan O Rosas
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.996

8.  Impacts of Low-Dose Total Glycosides of Tripterygium wilfordii plus Methotrexate on Immunological Function and Inflammation Level in Patients with Rheumatoid Arthritis.

Authors:  Yong Han; Jingri Jin; Fushun Wu; Zhiwei Wang
Journal:  Comput Math Methods Med       Date:  2022-08-01       Impact factor: 2.809

Review 9.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

10.  Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.

Authors:  Jake G Natalini; Joshua F Baker; Namrata Singh; Tina D Mahajan; Punyasha Roul; Geoffrey M Thiele; Brian C Sauer; Cheilonda R Johnson; Steven M Kawut; Ted R Mikuls; Bryant R England
Journal:  Ann Am Thorac Soc       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.